Heart failure & cardiomyopathiesResearch article

Frailty and Heart Failure: An Integrated Review of a Bidirectional Relationship

ESC Heart FailPublished

  • integrated review

Authors' conclusion

Future research should prioritise prospective validation of HF-specific frailty tools and randomised trials evaluating frailty-targeted interventions in HF populations.

Study context

Population
Older adults with heart failure and frailty

Main finding

As reported in the abstract

Frailty prevalence

Frailty in patients with chronic heart failure (HF), depending on clinical setting and assessment tool

15-76%

Prevalence in hospitalised patients with heart failure with preserved ejection fraction (HFpEF)

approaching 90%

Further findings

Frailty and incident HF

Frailty independently predicts incident HF and is associated with progressive deterioration in cardiac structure and function

HF and frailty progression

HF accelerates frailty progression through systemic inflammation, skeletal muscle hypoperfusion, sarcopenia, neurohormonal activation, malnutrition, and hospital-associated deconditioning

Consequences of frailty

Frailty contributes to impaired quality of life, reduced self-care capacity, prolonged hospitalisation, poorer tolerance of guideline-directed medical therapy, and higher all-cause mortality risk

Original publication

Frailty and Heart Failure: An Integrated Review of a Bidirectional Relationship. ESC Heart Fail. Published 27 June 2026. doi:10.1093/eschf/xvag178

Summarised from the published abstract; every number is checked against it